Pharmaceutical Industry Information Portal


All posts by tag


NANOLEK will invest 5 billion rubles in the full production cycle

Nanolek, a biopharmaceutical company, announces a plan to invest 5 billion rubles over 3 years in its full-cycle vaccine production facility in the Kirov region and an R&D Center for Biotech Medicines in Moscow.

Yposkesi launches construction of its second commercial bioproduction site

Yposkesi, a leading Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies, announces the launch of project SKY, the construction of...

East-Pharm to Choose Kaluga SEZ

East-Pharm is a modern Russian high-tech pharmaceutical company specializing in the production of infusion solutions in accordance with GMP.

Cambrex Introduces New Kilogram-Scale GMP Manufacturing Capabilities at Tallinn, Estonia Facility

The site in Tallinn provides custom organic synthesis and contract research, analytical and development services, working on process development and scale-up synthesis to kilogram quantities.

Indian Panacea Biotec launches production of Sputnik V vaccine

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading vaccine and pharmaceutical producers in India, today...

Transition of Veterinary Manufacturers to the EAEU GMP Rules

In October 2020, the Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor) announced that from January 1, 2021, the Rules of Good Manufacturing Practice...

Expert Articles